152 related articles for article (PubMed ID: 9406694)
1. Perspectives on oncologic imaging with radiolabeled antibodies.
Goldenberg DM
Cancer; 1997 Dec; 80(12 Suppl):2431-5. PubMed ID: 9406694
[TBL] [Abstract][Full Text] [Related]
2. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
Goldenberg DM; Wegener W
Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
[TBL] [Abstract][Full Text] [Related]
3. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
[TBL] [Abstract][Full Text] [Related]
4. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
[TBL] [Abstract][Full Text] [Related]
5. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.
De Jager R; Abdel-Nabi H; Serafini A; Pecking A; Klein JL; Hanna MG
Semin Nucl Med; 1993 Apr; 23(2):165-79. PubMed ID: 8511602
[TBL] [Abstract][Full Text] [Related]
6. Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment.
Blend MJ; Hyun H; Kozloff M; Levi H; Mills GQ; Gasparini M; Buraggi G; Hughes L; Pinsky CM; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5764s-5770s. PubMed ID: 7493343
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer imaging with radiolabeled antibodies.
Goldenberg DM; Nabi HA
Semin Nucl Med; 1999 Jan; 29(1):41-8. PubMed ID: 9990682
[TBL] [Abstract][Full Text] [Related]
8. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
Oriuchi N
Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
[TBL] [Abstract][Full Text] [Related]
9. Imaging lung cancer with radiolabeled antibodies.
Breitz HB; Sullivan K; Nelp WB
Semin Nucl Med; 1993 Apr; 23(2):127-32. PubMed ID: 8390098
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
11. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m LL-2 Fab' monoclonal antibody imaging in acquired immune deficiency syndrome-related lymphoma.
Kramer EL; Volm M; Donahue B; Wasserheit C; Chapnick J; Sanger J; Koslow M
Cancer; 1997 Dec; 80(12 Suppl):2469-77. PubMed ID: 9406697
[TBL] [Abstract][Full Text] [Related]
13. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
[TBL] [Abstract][Full Text] [Related]
14. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).
Lamonica D; Czuczman M; Nabi H; Klippenstein D; Grossman Z
Cancer Biother Radiopharm; 2002 Dec; 17(6):689-97. PubMed ID: 12537673
[TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer. Radiologic staging.
Thoeni RF
Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunolocalization of primary and metastatic breast cancer.
Baum RP; Brümmendorf TH
Q J Nucl Med; 1998 Mar; 42(1):33-42. PubMed ID: 9646643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]